Arctium lappa

Arctium lappa (burdock root) contains bioactive compounds including arctigenin and chlorogenic acid that exhibit anti-inflammatory and antioxidant properties. Research shows it may help reduce ovarian volume in PCOS and improve inflammatory markers in osteoarthritis through modulation of inflammatory pathways.

Origin & History

Arctium lappa L., commonly known as burdock or bardana, is a biennial plant belonging to the Asteraceae family. The medicinal preparations are primarily derived from the root, which is processed into various forms including hydroalcoholic extracts, aqueous extracts, powders, and standardized extracts containing purified lignans.

Historical & Cultural Context

A. lappa has been used in traditional medicine worldwide and is classified as a medicinal edible homologous plant, suggesting long-standing use in multiple traditional medicine systems. However, specific details regarding which traditional systems and the duration of historical use are not detailed in current literature.

Health Benefits

• May reduce ovarian volume and oxidative stress markers in women with PCOS (moderate evidence - one RCT with 60 subjects)
• Shows potential for improving inflammatory status in knee osteoarthritis patients (preliminary evidence - small clinical trial)
• May stimulate collagen synthesis and increase hyaluronan levels when applied topically (moderate evidence - 12-week human study)
• Demonstrates hepatoprotective effects against drug-induced liver toxicity (preliminary evidence - animal studies only)
• May help manage autoimmune conditions through immunomodulatory effects (preliminary evidence - primarily animal models)

How It Works

Arctium lappa's primary bioactive compound arctigenin inhibits nuclear factor-κB (NF-κB) signaling pathways, reducing pro-inflammatory cytokine production including TNF-α and IL-6. Chlorogenic acid provides additional antioxidant effects by scavenging reactive oxygen species and modulating oxidative stress markers. The plant's lignans may also influence hormonal pathways through estrogen receptor modulation.

Scientific Research

Clinical evidence remains limited, with a recent RCT (2023-2024) showing 460 mg/day of A. lappa root powder reduced ovarian volume in 60 PCOS patients over 12 weeks. A systematic review of immunological and dermatological outcomes emphasizes that current literature lacks standardized dosing and robust randomized clinical trials, with most evidence confined to case reports, small pilot trials, or preclinical studies.

Clinical Summary

One randomized controlled trial with 60 women showed Arctium lappa supplementation significantly reduced ovarian volume and improved oxidative stress markers in PCOS patients. A small clinical trial demonstrated potential benefits for inflammatory status in knee osteoarthritis patients. Limited evidence suggests effects on collagen synthesis, though this requires further investigation. Current clinical evidence remains preliminary with small sample sizes requiring larger, longer-term studies for definitive conclusions.

Nutritional Profile

Arctium lappa (burdock root) contains moderate carbohydrate content (approximately 17-20g per 100g fresh root), primarily as inulin-type fructooligosaccharides (inulin content 3.5-4.0g per 100g fresh weight, up to 45% dry weight), which serve as prebiotic dietary fiber with low glycemic impact and enhanced gut microbiota bioavailability. Protein content is relatively low at approximately 1.5-2.0g per 100g fresh root, containing essential amino acids including arginine and aspartic acid. Fat content is minimal at 0.1-0.2g per 100g. Key micronutrients include potassium (approximately 308mg per 100g), magnesium (38mg per 100g), phosphorus (51mg per 100g), calcium (41mg per 100g), and iron (0.8mg per 100g). Manganese is notably present at approximately 0.26mg per 100g. Vitamin C content ranges from 3-5mg per 100g fresh root, with small amounts of B-vitamins including thiamine (B1: ~0.01mg), riboflavin (B2: ~0.03mg), and niacin (B3: ~0.3mg) per 100g. Bioactive compounds include caffeoylquinic acid derivatives (chlorogenic acid, 3,5-dicaffeoylquinic acid), arctiin and arctigenin (lignans, approximately 0.01-0.05% dry weight), sesquiterpene lactones, and polyphenolic antioxidants including quercetin and luteolin glycosides. Arctigenin demonstrates moderate oral bioavailability following gut microbial conversion from arctiin. Inulin bioavailability is largely colonic (prebiotic fermentation) rather than systemic. Polyphenol bioavailability is estimated at 10-30% depending on food matrix and gut microbiome composition.

Preparation & Dosage

Root powder: 460 mg/day (studied for PCOS over 12 weeks). Topical formulations: Applied to skin for 12 weeks in clinical studies. Purified lignans: 25 mg/kg/day arctiin orally or 15 mg/kg arctigenin intraperitoneally in animal studies only. Standardization information is largely absent from clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, Turmeric, Green tea extract, Quercetin, Resveratrol

Safety & Interactions

Arctium lappa is generally well-tolerated when used appropriately, though allergic reactions may occur in sensitive individuals. It may interact with diabetes medications by enhancing glucose-lowering effects, requiring blood sugar monitoring. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals with kidney disorders should use caution as burdock root may have diuretic properties.